Clinical Trial Update: Angiographic Delivery of AD-MSC for Ulcerative Colitis [Phase 1]

View source ↗

Summary

Phase 1 trial update on angiographic delivery of adipose-derived mesenchymal stem cells for ulcerative colitis; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• AD-MSC (Adipose-Derived Mesenchymal Stem Cells) (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Ulcerative Colitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING